CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 6,000 shares at an average $186.44 ($1,118,613)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 3,415 shares at $192.00 ($655,680)
- 4 Grant or award EVP & Chief Financial Officer acquired 11,857 shares (grant or award)
- 4 Grant or award EVP, Chief Commercial Officer acquired 9,782 shares (grant or award)
- 4 Grant or award EVP, Global Head of R&D & CMO acquired 14,822 shares (grant or award)
- 4 Open-market sale SVP, Chief Accounting Officer sold 2,370 shares at an average $192.60 ($456,466)
- 4 Grant or award President & CEO acquired 44,465 shares (grant or award)
- 4 Grant or award Director acquired 1,527 shares (grant or award)
- 4 Open-market sale EVP & Chief Legal Officer sold 55,600 shares at an average $191.56 ($10,650,482)
- 4 Open-market sale SVP, Technical Operations sold 5,343 shares at $194.49 ($1,039,134)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-K Report Annual Report
Page 7 of 110 · 2,194 filings